244 related articles for article (PubMed ID: 17981628)
1. The biological role of HGF-MET axis in tumor growth and development of metastasis.
Lesko E; Majka M
Front Biosci; 2008 Jan; 13():1271-80. PubMed ID: 17981628
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
Matsumoto K; Nakamura T; Sakai K; Nakamura T
Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Matrix Influencing HGF/c-MET Signaling Pathway: Impact on Cancer Progression.
Noriega-Guerra H; Freitas VM
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30352967
[TBL] [Abstract][Full Text] [Related]
4. Filamin a mediates HGF/c-MET signaling in tumor cell migration.
Zhou AX; Toylu A; Nallapalli RK; Nilsson G; Atabey N; Heldin CH; Borén J; Bergo MO; Akyürek LM
Int J Cancer; 2011 Feb; 128(4):839-46. PubMed ID: 20473907
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor/MET in cancer progression and biomarker discovery.
Matsumoto K; Umitsu M; De Silva DM; Roy A; Bottaro DP
Cancer Sci; 2017 Mar; 108(3):296-307. PubMed ID: 28064454
[TBL] [Abstract][Full Text] [Related]
6. HGF/SF-met signaling in the control of branching morphogenesis and invasion.
Zhang YW; Vande Woude GF
J Cell Biochem; 2003 Feb; 88(2):408-17. PubMed ID: 12520544
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
[TBL] [Abstract][Full Text] [Related]
8. Targeting the hepatocyte growth factor/Met pathway in cancer.
De Silva DM; Roy A; Kato T; Cecchi F; Lee YH; Matsumoto K; Bottaro DP
Biochem Soc Trans; 2017 Aug; 45(4):855-870. PubMed ID: 28673936
[TBL] [Abstract][Full Text] [Related]
9. The HGF-met signaling axis: emerging themes and targets of inhibition.
Steffan JJ; Coleman DT; Cardelli JA
Curr Protein Pept Sci; 2011 Feb; 12(1):12-22. PubMed ID: 21190524
[TBL] [Abstract][Full Text] [Related]
10. Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels.
Mineo R; Costantino A; Frasca F; Sciacca L; Russo S; Vigneri R; Belfiore A
Endocrinology; 2004 Sep; 145(9):4355-65. PubMed ID: 15192042
[TBL] [Abstract][Full Text] [Related]
11. NK4 gene therapy targeting HGF-Met and angiogenesis.
Matsumoto K; Nakamura T
Front Biosci; 2008 Jan; 13():1943-51. PubMed ID: 17981681
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin contributes to hepatocyte growth factor-induced tumor growth and metastasis formation.
Ariztia EV; Subbarao V; Solt DB; Rademaker AW; Iyer AP; Oltvai ZN
Exp Cell Res; 2003 Aug; 288(2):257-67. PubMed ID: 12915117
[TBL] [Abstract][Full Text] [Related]
13. HGF-MET cascade, a key target for inhibiting cancer metastasis: the impact of NK4 discovery on cancer biology and therapeutics.
Mizuno S; Nakamura T
Int J Mol Sci; 2013 Jan; 14(1):888-919. PubMed ID: 23296269
[TBL] [Abstract][Full Text] [Related]
14. Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion.
Cao HH; Cheng CY; Su T; Fu XQ; Guo H; Li T; Tse AK; Kwan HY; Yu H; Yu ZL
Mol Cancer; 2015 May; 14():103. PubMed ID: 25971889
[TBL] [Abstract][Full Text] [Related]
15. Increased HGF Expression Induces Resistance to c-MET Tyrosine Kinase Inhibitors in Gastric Cancer.
Ahn SY; Kim J; Kim MA; Choi J; Kim WH
Anticancer Res; 2017 Mar; 37(3):1127-1138. PubMed ID: 28314274
[TBL] [Abstract][Full Text] [Related]
16. The MET receptor tyrosine kinase in invasion and metastasis.
Benvenuti S; Comoglio PM
J Cell Physiol; 2007 Nov; 213(2):316-25. PubMed ID: 17607709
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor in physiology and infectious diseases.
Imamura R; Matsumoto K
Cytokine; 2017 Oct; 98():97-106. PubMed ID: 28094206
[TBL] [Abstract][Full Text] [Related]
18. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.
Abounader R; Ranganathan S; Lal B; Fielding K; Book A; Dietz H; Burger P; Laterra J
J Natl Cancer Inst; 1999 Sep; 91(18):1548-56. PubMed ID: 10491431
[TBL] [Abstract][Full Text] [Related]
19. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
20. Activation of the HGF/c-Met axis in the tumor microenvironment: A multispecies model.
Konstorum A; Lowengrub JS
J Theor Biol; 2018 Feb; 439():86-99. PubMed ID: 29203124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]